Package 80644-0013-1

{"route": ["SUBCUTANEOUS"], "spl_id": "45c0e8f1-4639-dbc8-e063-6394a90a7cd9", "openfda": {"nui": ["N0000190852", "N0000193923", "N0000009345"], "unii": ["AD4J2O47FQ"], "rxcui": ["2535238", "2535243", "2535247", "2535249"], "spl_set_id": ["c6c32b47-c47c-4a7f-8d4d-23578f663217"], "pharm_class_pe": ["Increased Glycogenolysis [PE]"], "pharm_class_epc": ["Antihypoglycemic Agent [EPC]"], "pharm_class_moa": ["Glucagon Receptor Agonists [MoA]"], "manufacturer_name": ["Zealand Pharma US, Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 CONTAINER in 1 PACKAGE (80644-0013-1)  / 1 SYRINGE, GLASS in 1 CONTAINER / .6 mL in 1 SYRINGE, GLASS", "package_ndc": "80644-0013-1", "marketing_start_date": "20210405"}, {"sample": false, "description": "2 PACKAGE in 1 CARTON (80644-0013-2)  / 1 CONTAINER in 1 PACKAGE / 1 SYRINGE, GLASS in 1 CONTAINER / .6 mL in 1 SYRINGE, GLASS", "package_ndc": "80644-0013-2", "marketing_start_date": "20210405"}], "brand_name": "Zegalogue", "product_id": "80644-0013_45c0e8f1-4639-dbc8-e063-6394a90a7cd9", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Antihypoglycemic Agent [EPC]", "Glucagon Receptor Agonists [MoA]", "Increased Glycogenolysis [PE]"], "product_ndc": "80644-0013", "generic_name": "dasiglucagon", "labeler_name": "Zealand Pharma US, Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Zegalogue", "active_ingredients": [{"name": "DASIGLUCAGON", "strength": ".6 mg/.6mL"}], "application_number": "NDA214231", "marketing_category": "NDA", "marketing_start_date": "20210405", "listing_expiration_date": "20261231"}